Top compounds associated with response to UCN


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate FIMM pan-cancer AAC -0.051 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.012 0.7
mRNA PD-0325901 CCLE pan-cancer AAC -0.015 0.7
mRNA AZD6244 CCLE pan-cancer AAC -0.015 0.7
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA SGC0946 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV